info@synchemia.com | sales@synchemia.com 
9766925136 
Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142451 |
| CAS No | NA |
| Mol.F. | C23H26N8O4 |
| Mol.Wt. | 478.51 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142452 |
| CAS No | NA |
| Mol.F. | C24H23ClN8O5 |
| Mol.Wt. | 538.95 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142453 |
| CAS No | NA |
| Mol.F. | C36H39Cl2N9O8 |
| Mol.Wt. | 796.66 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142454 |
| CAS No | NA |
| Mol.F. | C14H13ClN4O4S |
| Mol.Wt. | 368.79 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142455 |
| CAS No | NA |
| Mol.F. | C15H15ClN4O5 |
| Mol.Wt. | 366.76 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142456 |
| CAS No | NA |
| Mol.F. | C21H27ClN6O4 |
| Mol.Wt. | 462.94 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142457 |
| CAS No | NA |
| Mol.F. | C8H20N2O8P2 |
| Mol.Wt. | 334.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142458 |
| CAS No | NA |
| Mol.F. | C4H12N2O8P2 |
| Mol.Wt. | 278.1 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142459 |
| CAS No | 6949-28-6 |
| Mol.F. | C12H26N2O |
| Mol.Wt. | 214.35 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142460 |
| CAS No | NA |
| Mol.F. | C23H29N9O2 |
| Mol.Wt. | 463.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142461 |
| CAS No | NA |
| Mol.F. | C24H29N9O3 |
| Mol.Wt. | 491.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142462 |
| CAS No | NA |
| Mol.F. | C21H23N9O4 |
| Mol.Wt. | 465.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142463 |
| CAS No | NA |
| Mol.F. | C21H24N8O3 |
| Mol.Wt. | 436.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142464 |
| CAS No | NA |
| Mol.F. | C21H24N8O3 |
| Mol.Wt. | 436.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142465 |
| CAS No | NA |
| Mol.F. | C17H15N5O8S |
| Mol.Wt. | 449.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142466 |
| CAS No | NA |
| Mol.F. | C17H16N4O7S |
| Mol.Wt. | 420.4 g/mol |
| INV STATUS | UNDER SYNTHESIS |
